Search results for "Side effects"
RSV vaccines new tool for physicians
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://immattersacp.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023
Catch Parkinson's early for better support
Comanaging patients with Parkinson's disease involves a back-and-forth relationship between the primary care physician and the neurologist over the course of a slow but progressive disease.
https://immattersacp.org/archives/2020/04/catch-parkinsons-early-for-better-support.htm
1 Apr 2020
Pressing forward with primary prevention for CVD
This issue includes stories on managing cardiovascular disease, prescribing benzodiazepines, and diagnosing depression in the elderly.
https://immattersacp.org/archives/2022/02/pressing-forward-with-primary-prevention-for-cvd.htm
1 Feb 2022
Hydrochlorothiazide no better than placebo for preventing kidney stone recurrence
A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
https://immattersacp.org/weekly/archives/2023/03/07/1.htm
7 Mar 2023
Warning on steroids; approval for soft-tissue sarcoma drug
This column reviews a warning on testosterone and other anabolic androgenic steroids and approval of a new drug to treat certain adults with soft-tissue sarcoma.
https://immattersacp.org/archives/2017/01/fda-update.htm
1 Jan 2017
New warnings added on multiple diabetes drugs
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
https://immattersacp.org/archives/2015/11/fda.htm
1 Nov 2015
Details debated in breast screening
Amid a thicket of competing and sometimes conflicting studies about breast cancer screening, medical groups have adopted differing stances on how to address the conundrum of harms versus benefits.
https://immattersacp.org/archives/2017/03/breast-screening.htm
1 Mar 2017
Warning on NSAIDs; new schizophrenia drug approved
This update covers a strengthened warning on NSAIDs and a new drug to treat schizophrenia.
https://immattersacp.org/archives/2015/09/fda.htm
1 Sep 2015
No interventions proven to prevent late-life dementia, systematic reviews find
The reviews examined physical activity, prescription medications, cognitive training, and over-the-counter vitamins and supplements.
https://immattersacp.org/weekly/archives/2017/12/19/1.htm
19 Dec 2017
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015